Home
    Disclaimer
    ← Back to 3,4-MDPV

    3,4-MDPV Stats & Data

    Stimulant
    MDPV
    Chemical Class Cathinone
    Psychoactive Class Stimulant

    Effect Profile

    Curated + 105 Reports
    Stimulant 8.8

    Strong stimulation, euphoria, focus, and anxiety/jitters

    Stimulation / Energy×3
    1010
    Euphoria / Mood Lift×2
    108.1
    Focus / Productivity×2
    107.0
    Anxiety / Jitters×1
    1010
    Catalog Erowid
    Based on reports from:
    Erowid Experience Reports PsychonautWiki 3,4-MDPV

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 1h Half tolerance 4d Baseline ~5d

    Experience Report Analysis

    Erowid
    105 Reports
    2005–2017 Date Range
    87 With Age Data
    29 Effects Detected

    Demographics

    Gender Distribution

    Age Distribution

    Reports Over Time

    Effect Analysis

    Erowid

    Effects aggregated from 105 experience reports (105 Erowid)

    105 Reports
    29 Effects Detected
    10 Positive
    13 Adverse
    6 Neutral

    Effect Sentiment Distribution

    Confidence Distribution

    Positive Effects 10

    Stimulation 57.1% 70%
    Euphoria 54.3% 70%
    Focus Enhancement 35.2% 70%
    Empathy 25.7% 70%
    Music Enhancement 20.0% 70%
    Tactile Enhancement 18.1% 70%
    Color Enhancement 12.4% 70%
    Creativity Enhancement 10.5% 70%
    Introspection 8.6% 70%
    Body High 4.8% 70%

    Adverse Effects 13

    Anxiety 49.5% 70%
    Increased Heart Rate 25.7% 70%
    Confusion 19.0% 70%
    Headache 12.4% 70%
    Jaw Clenching 12.4% 70%
    Psychosis 11.4% 70%
    Nausea 11.4% 70%
    Pupil Dilation 10.5% 70%
    Muscle Tension 9.5% 70%
    Sweating 8.6% 70%
    Motor Impairment 6.7% 70%
    Memory Suppression 2.9% 70%
    Appetite Suppression 2.9% 70%

    Dose-Response Correlation

    How effect frequency changes across dose levels

    View data table
    Effect Common (n=10)
    Euphoria 100.0%
    Stimulation 90.0%
    Empathy 60.0%
    Focus Enhancement 40.0%
    Anxiety 40.0%
    Sedation 30.0%
    Increased Heart Rate 30.0%
    Confusion 20.0%
    Sweating 20.0%
    Muscle Tension 20.0%
    Headache 20.0%
    Visual Distortions 20.0%
    Jaw Clenching 20.0%
    Pupil Dilation 20.0%

    Dose–Effect Mapping

    Experience Reports

    How reported effects shift across dose tiers, based on 105 experience reports.

    Limited tier coverage — most reports fall within the Common range. Effects at other dose levels may not be represented.

    Effect Common (n=10)
    euphoria
    100%
    stimulation
    90%
    empathy
    60%
    focus enhancement
    40%
    anxiety
    40%
    sedation
    30%
    increased heart rate
    30%
    confusion
    20%
    sweating
    20%
    muscle tension
    20%
    headache
    20%
    visual distortions
    20%
    jaw clenching
    20%
    pupil dilation
    20%

    Dosage Distribution

    Dose distribution from experience reports

    Median: 10.0 mg IQR: 5.0–10.0 mg n=19

    Form / Preparation

    Most common forms and preparations reported

    Body-Weight Dosing

    Dose relative to body weight from reports with weight data

    Median: 0.11 mg/kg IQR: 0.065–0.149 mg/kg n=19

    Redose Patterns

    Redosing behavior across 78 reports

    33.3% Redosed
    1.6 Avg Doses
    105m Median Interval
    Read full reports on Erowid →
    ← Back to 3,4-MDPV